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objectives In a prevention of mother-to-child HIV transmission (PMTCT) programme, to determine:
the acceptability of offering ‘opt-out’ voluntary counselling and HIV-testing (VCT); the progressive loss
to follow up of HIV-positive mothers during the antenatal period, at delivery and to the 6-month
postnatal visit; and the proportion of missed deliveries in the district.
design Cohort study.
methods Review of routine antenatal, VCT and PMTCT registers.
results Of 3136 new antenatal mothers, 2996 [96%, 95% conﬁdence interval (CI): 95–97] were pre-
test counselled, 2965 (95%, CI: 94–96) underwent HIV-testing, all of whom were post-test counselled.
Thirty-one (1%) mothers refused HIV-testing. A total of 646 (22%) individuals were HIV-positive, and
were included in the PMTCT programme. Two hundred and eighty-eight (45%) mothers and 222 (34%)
babies received nevirapine. The cumulative loss to follow up (n ¼ 646) was 358 (55%, CI: 51–59) by the
36-week antenatal visit, 440 (68%, CI: 64–71) by delivery, 450 (70%, CI: 66–73) by the ﬁrst postnatal
visit and 524 (81%, CI: 78–84) by the 6-month postnatal visit. This left just 122 (19%, CI: 16–22) of the
initial cohort still in the programme. The great majority (87%) of deliveries occurred at peripheral sites
where PMTCT was not available.
conclusions In a rural district hospital setting, at least 9 out of every 10 mothers attending antenatal
services accepted VCT, of whom approximately one-quarter were HIV-positive and included in the
PMTCT programme. The progressive loss to follow up of more than three-quarters of this cohort by the
6-month postnatal visit demands a ‘different way of acting’ if PMTCT is to be scaled up in our setting.
keywords scaling-up, Voluntary counselling HIV-testing, prevention of mother-to-child HIV trans-
mission, nevirapine, Malawi
Introduction
Mother-to-child transmission (MTCT) is the main mode of
acquisition of HIV infection in children and each day an
estimated 1600 children born to HIV-infected mothers
become infected, the great majority in sub-Saharan Africa
(Newell 2003).
Single dose intra-partum and neonatal nevirapine is
considered an effective and relatively easy medical inter-
vention that has been shown to reduce the risk of HIV
transmission by almost half (Guay et al. 1999; Nolan et al.
2002). In 2000, WHO/UNAIDS recommended that this
intervention coupled with voluntary counselling and HIV-
testing (VCT) be made available as a minimum standard
package of care for all HIV-positive women and their
children (WHO 2004a,b).
Malawi is a small and impoverished country in sub-
Saharan Africa with about 10 million inhabitants and is
facing a serious epidemic of HIV and AIDS. HIV preval-
ence rates in pregnant women countrywide range from
16% to 36% (MOHP 2003a). In 2003, 520 000 women of
child-bearing age were estimated to be infected with HIV
(MOHP 2003a) and about 35% of these mothers are likely
to transmit HIV to their newborns. Interventions to reduce
this high risk of HIV transmission are thus considered an
urgent public health priority for Malawi.
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child HIV transmission (PMTCT) was launched in Thyolo
district in rural southern Malawi, where an estimated 27%
(25–31%) of mothers attending antenatal care services are
HIV seropositive (MOHP 2003b). The district reports an
average of 20 000 deliveries per year, of which an
estimated 5400 would occur in HIV-positive mothers.
Assuming an estimated MTCT risk of 35% (20–45%)
(WHO 2004a,b) approximately 1890 infants might thus
become infected through MTCT.
This review of programme data describes (i) the accep-
tability of offering ‘opt-out’ VCT within routine antenatal
services; (ii) the progressive loss to follow up of HIV-
positive mothers during the antenatal period, at delivery
and during a 6-month postnatal period and (iii) the
proportion of missed deliveries in the district.
Methods
Study setting and population
The study was conducted between March 2002 and
September 2003, in Thyolo district, a rural region in
Southern Malawi with an estimated population of 462 545
inhabitants in 2001 (NSO 2001). A one-year consecutive
cohort of mothers registered at the main public hospital,
Thyolo District Hospital (Figure 1) between March 2002
and February 2003 were involved in the study. The
estimated population of the coverage area of this hospital
involves the entire district population and was estimated at
474 646 for the study period (estimated annual population
growth rate of 2.4%).
Thyolo district also has 11 public health centres as well
as 57 ofﬁcially recognized traditional birth attendant
(TBA) clinics offering antenatal, natal and postnatal
services. Both peripheral health centre staff and TBAs are
trained and supervised on a monthly basis by a mobile
team. They receive basic delivery equipment and a regular
monthly supply of consumables including material for
sterilization, gloves, aprons, iron, folic acid and anti-
malarials. All health center staff and TBAs are made well
aware of the indications for referral to hospital (MOHP
2000). Health centres far away from Thyolo Hospital have
either have a telephone or are part of a district HF radio
network that can be used to request for an ambulance
based at the Thyolo district hospital. TBAs also have access
to this service.
Antenatal clinic services in government facilities inclu-
ding the PMTCT service in Thyolo Hospital are offered
free of charge. TBAs charge 50–100 kwacha (approxi-
mately 1 USD) per delivery and often receive a present
from the family as part of the local tradition. Members of
the community, traditional leaders and TBAs were aware
of the PMTCT programme through speciﬁc information,
education and communications sessions. PMTCT services
were only offered at the Thyolo District Hospital.
Voluntary counselling and HIV-testing and care related
activities
Since March 2002, mothers in the waiting area of the
antenatal clinic are given a motivation talk on VCT and the
available package of PMTCT services. All mothers are
systematically offered pre-test counselling on a one-to-one
basis and undergo HIV-testing on an ‘opt-out’ basis. The
pre-test counselling process essentially involves giving
general information about HIV/AIDS and its prevention
with particular emphasis on mother-to-child HIV trans-
mission; reasons for recommending the HIV-test including
details on services that will be made available to the
mother and child in the event of a positive test, and the
right for the mother to delay or refuse an HIV-test. HIV-
testing is conducted on site using rapid whole blood test
kits [Determine HIV-1/HIV-2 (Abbott Laboratories,
Tokyo, Japan) and Uni-Gold
TM HIV-1/HIV-2 (Trinity
Biotech, Ireland)], according to the WHO strategy II for
HIV antibody testing (UNAIDS/WHO 1997). Those who
undergo HIV-testing are offered post-test counselling and
HIV-positive mothers are integrated into the PMTCT
programme. These mothers receive speciﬁc counselling on
peri- and neo-natal nevirapine, family planning as well as
infant feeding options. Counselling is done by full-time
trained midwife-counsellors. Each complete counselling
session (pre- and post-test counselling) takes an average of
45–60 min. One counsellor is expected to cover approxi-
mately 8–10 complete counselling sessions per day. Addi-
tional personnel required for counselling were made
available with support from MSF.
Routine screening of HIV related opportunistic infec-
tions, cotrimoxazole preventive prophylaxis and access to
treatment of opportunistic infections are part of the
package offered by the programme. Links have also been
developed with community care groups and volunteers
who provide continuing support. At the time of imple-
menting this study, highly active antiretroviral treatment
was not yet available in the district.
Steps in providing prevention of mother-to-child HIV
transmission for HIV-positive mothers
The PMTCT activities as integrated within the routine
maternal and child health (MCH) package is shown in
Table 1. At 36 weeks the mother is given a single dose of
nevirapine (200 mg) to take at the onset of labour.
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ª 2005 Blackwell Publishing Ltd 1243Mothers are made aware of the limitations of nevirapine
(i.e. that it does not treat the mother, does not completely
prevent HIV transmission to the child, and that its
advantage is reduced with prolonged breastfeeding).
Nevirapine is to be taken at the start of labour (often at
home) and the patient is requested to present to Thyolo
Hospital Maternity for safe delivery.
Within 72 h of delivery, the baby is given a single dose of
2 mg/kg of nevirapine syrup by the midwife. In case a
mother is unable to make it to hospital for delivery she is
expected to return within 72 h of delivery to ensure
administration of nevirapine to the child. Counselling on
infant feeding options and support according to the
mother’s choice is given. In case she chooses bottle feeding,
artiﬁcial milk is provided free of charge for a period of
12 months. These mothers are offered cabergoline
(Caballero et al. 1991) in a single oral dose of 1 mg to be
taken immediately after delivery (in the delivery room) to
suppress breast milk production. Contraindications include
hypersensitivity to ergot alkaloids or bromocriptine, toxe-
mia of pregnancy and hypertension.
Appointments are given according to the MCH schedule
(Table 1). Co-trimoxazole prophylaxis is offered to infants
from 6 weeks to at least 6 months (Graham et al. 2000,
2001; WHO 2000). HIV-testing of the child is done at
18 months using rapid whole blood tests.
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Figure 1 Map of Thyolo district showing
the distribution of Thyolo District hospital
and 11 public health centres.
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Information on demographic characteristics, VCT, and
uptake of different components of the PMTCT package
were obtained from VCT, PMTCT registers and ante-
natal patient cards. Loss to follow up (drop out) was
deﬁned as failure to present back to the PMTCT
programme between entries during the antenatal period
to the 6-month postnatal visit. The number of expected
deliveries in Thyolo district for 2002 was calculated
considering that 5% of the total population are pregnant
mothers who deliver each year. The total district
population for 2002 (473 646) took into consideration
an annual population growth rate of 2.4% on the 2001
population census ﬁgure of 462 545 inhabitants (NSO
2001).
Data on the proportion of deliveries that occur at public
health facilities, and TBA sites were obtained from
quarterly reports available at the district health ofﬁce. Data
analysis was done using the Epi Info software (Version
6.04, Centers for Diseases Control and Prevention, Atlanta
GA, USA). Conﬁdence intervals (CI) where applied to
proportions expressed in percentages (%) was set at 95%
with a 5% error risk.
Results
Characteristics of the study population
A total of 3136 mothers (median age 22 years) were
registered in the antenatal clinic of Thyolo district hospital
between March 2002 and February 2003. Of these 3041
Table 1 Summary of PMTCT interventions as part of an integrated package of routine mother and child care services in Thyolo, Malawi
Period Interventions
Antenatal visit 1 (12–34 weeks) STI counselling, syphilis testing/treatment
STI counselling, syphilis testing/treatment
Pre-test counselling and testing
Post-test counselling including PMTCT counselling
Consent for nevirapine for HIV-positive mothers
Promotion of exclusive breast-feeding for HIV-negative mothers
Infant feeding counselling and family planning
counselling for HIV-positive mothers
Management of opportunistic infections and cotrimoxazole prophylaxis
Iron/folic acid and vitamin A supplementation
Antimalarial prophylaxis
Anti-tetanus vaccination schedule (if unvaccinated)
Antenatal visit 2 (34–36 weeks) Repeat counselling for HIV-positive mothers
(condoms, family planning and nutrition)
Nevirapine related counselling
Mother given 200 mg nevirapine to take at onset of labour
Labour/delivery Nevirapine 200 mg to be taken at onset of labour
Avoidance of unnecessary invasive procedures
Universal precautions
Immediate post-partum (48–72 h) Nevirapine 2 mg/kg stat dose for baby
Support to infant feeding (as per choices of the mother)
Carbergoline (dostinex) for breast milk suppression
if the mother’s choice is artiﬁcial feeding
BCG, Polio 0
Family planning, promotion of condom use
Referral to home based care and support groups if needed
Vitamin A supplementation
According to EPI schedule
(6, 10 and 14 weeks and 6, 12 and 18 months)
DPT1, DPT2, DPT3, Polio, Measles
Cotrimoxazole prophylaxis from 6 weeks of age to at least 6 months
Support to feeding
Growth monitoring
HIV screening of child at 18 months HIV-testing of child
Referral to HIV care clinic (if HIV-positive) and home based care
STI, Sexually transmitted infections; PMTCT, prevention of mother-to-child HIV transmission; EPI, expanded programme on
immunization; BCG, bacillus Calmette Guerin; DPT, triple vaccine containing Diptheria, Pertusis and Tetanus.
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were single. The mothers were farmers (96%), housewives
(2%), civil servants (1%) and businesswomen (1%).
Voluntary counselling and HIV-testing
Of 3136 registered mothers, 2996 (96%, CI: 95–97) were
pre-test counselled and 2965 (95%, CI: 94–96) underwent
HIV-testing as well as post-test counselling (Figure 2). Six
hundred and forty six (22%) were found HIV-positive and
included in the PMTCT programme. Thirty-one mothers
refused HIV-testing. Fifty-one (8%) mothers were in WHO
clinical stage III or IV and placed on cotrimoxazole
prophylaxis. The median period between registration at the
antenatal clinic and post-test counselling was one day
(range: 1–020). Forty-nine (8%) of partners of HIV-
positive mothers were counselled, all of whom underwent
HIV-testing.
All antenatal clinic consultations
(March 2002 – February 2003)  
n = 3136
140 refused  pre-test counselling
(wanted to receive consent from 
husband  and did not return)
2996 (96%, CI: 95–97) pre-test 
counselled
31(1%) refused HIV testing
2319  HIV 
negative
646 (22%) HIV
positive Mothers 
2319 post-test 
counselled
288 (45%, CI: 41– 48)
returned for  nevirapine 
at 36 weeks 
206 (32%, CI: 28–35)
returned for hospital 
delivery 
122  return at the 6
month  post-natal visit
(19%, CI: 16–22) of the 
HIV- positive cohort of 
mothers) 
222 (34%, CI: 31–38)
babies received
nevirapine at hospital 
16 newborns
referred by 
TBA’s for 
nevirapine  
*196 (30%, CI: 27–34)
babies arrive at post-
natal clinic
105 (54%) opt 
for EAF 
91 (46%) opt 
for EBF
2965 (95%, CI: 94–96) HIV test 
done
646 post-test
counselled 
Abbreviations:
CI: 95% confidence interval
TBA - Traditional birth attendant 
EAF - Exclusive artificial feeding 
EBF – Exclusive breast feeding 
49(8%) partners
counselled and 
tested  
65 (53%) on EAF
59 (48%) on EBF
* All had been delivered at 
Thyolo hospital and had 
received nevirapine.
Figure 2 Uptake of voluntary counselling,
HIV testing, and key components of the
mother-to-child transmission prevention
program in Thyolo hospital (ﬁrst antenatal
contact to the 6 month post natal visit).
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and loss to follow up during antenatal care, at delivery and
during a 6-month postnatal period
Figure 2 illustrates the uptake of the different key compo-
nents of the PMTCT package (including the proportion
that opted for exclusive artiﬁcial feeding and breast
feeding) by HIV-positive mothers. Figure 3 shows loss to
follow up at different stages of the programme. Of the 646
HIV-positive mothers, the cumulative loss to follow up was
358 (55%, CI: 51–59) by the 36-week antenatal visit, 440
(68%, CI: 64–71) by the time of delivery, 450 (70%, CI:
66–73) by the ﬁrst postnatal visit and 524 (81%, CI: 78–
84) by the 6-month postnatal visit. Thus only 122 (19%,
CI: 16–22) HIV-positive mothers and their infants were
still in the programme 6 months after delivery.
To compare the loss to follow up from the PMTCT
programme during the antenatal period (the period during
which 55% of loss occurred, Figure 3) with the general
cohort of mothers attending antenatal services at the same
hospital, we retrospectively reviewed antenatal registers for
the year 2002. Of 2806 new antenatal visits, only 1112
(40%, CI: 38–41) presented at the scheduled 34–36-week
visit, representing a 60% loss to follow up. The pattern of
loss to follow up from general antenatal care at Thyolo
hospital is thus similar to what was observed in the
PMTCT programme.
Missed HIV-positive deliveries at Thyolo hospital
maternity and other known delivery sites in Thyolo
During the study period 2502 deliveries took place at the
Thyolo district hospital. Assuming an HIV prevalence rate
of 22% (similar to that found among antenatal mothers
who underwent HIV-testing in this study), an estimated
550 HIV-positive deliveries should have occurred in the
hospital maternity. Since 206 of the 550 deliveries were
mothers known to be registered in the PMTCT pro-
gramme, an estimated 344 (63%, CI: 58–64) HIV-positive
deliveries that occurred in the maternity were considered
missed.
A retrospective review of reported deliveries for 2002
was conducted to determine where mothers deliver in the
district. Of the total 23 682 expected deliveries for the year
period, 2502 (11%) deliveries occurred in Thyolo hospital,
7532 (32%) in peripheral health facilities and 10 503
(44%) at registered TBA sites. Thus, the great majority
(87%) of all deliveries in the district occurred within the
network of known sites that offer antenatal and delivery
services in the district. The rest, comprising around 13%,
were considered non-documented deliveries, either occur-
ring at unrecognized TBA sites or at home.
Discussion
This study shows that in a rural district hospital setting, at
least 9 out of every 10 mothers attending antenatal services
accept VCT of whom approximately one-quarter are HIV-
positive and enter the PMTCT programme. However, a
progressive loss to follow up of over three-quarters of the
HIV-positive cohort by the 6-month postnatal visit chal-
lenges the possible impact and credibility of the current
programme and demands a new way of thinking for scaling
up PMTCT in our setting.
High VCT uptake in our setting is encouraging and might
be due to a number of reasons. First, VCT is fully integrated
into the antenatal care circuit and all mothers are system-
atically offered this service on a one-to-one basis. Not
undergoing HIV-testing would thus mean ‘opting-out’. This
strategy is likely to have reduced the possibility of stigma on
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Figure 3 Loss to follow up of HIV-positive
mothers (n-646) from a PMTCT program
between entry and the 6 month post-natal
visit Thyolo district hospital, Malawi
(February 2002 to September 2003).
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‘opt-in’ approach was used. We have had a similar
encouraging experience with the opt-out VCT approach
among patients with tuberculosis in the same setting
(Zachariah et al. 2002). Second, VCT units are well staffed
with trained counsellors, have adequate space to ensure
privacy and offer rapid on-site HIV-testing. These addi-
tional resources avoided undue delays in CVT as well as the
need for a return visit for results. Third, VCT serves as the
entry point to accessing free management of opportunistic
infections, cotrimoxazole prophylaxis, and the possibility
of referral to a network of community volunteers who
provide continuing care and social support. In a resource
poor setting where effective and affordable interventions to
reduce morbidity and mortality in HIV-positive individuals
are still limited, it is likely that these factors could have
acted as incentives for VCT. Since VCT is considered an
entry point to a potential range of prevention and care
related interventions (VCT group 2000; Sweat et al. 2000;
WHO 2004a,b), high acceptability provides a potential
‘opportunity’ for introducing such interventions.
However, the high and progressive dropout rate impedes
the beneﬁts of this opportunity and raises serious concerns
on the impact and credibility of this programme. Assuming
that single dose nevirapine given to both the mother and
newborn would reduce by 41% the estimated MTCT risk
of 33% in a breast-feeding population (Guay et al. 1999),
about 206 undetected HIV-positive mothers and newborns
would have beneﬁted from this intervention (Figure 2).
This translates to 27 prevented HIV-infections, a small
number in terms of impact when compared to the planned
resources of between USD 100 000–120 000 (4444$/pre-
vented infection) invested at the beginning of 2002 and
2003 for staff salaries (18%), training (6%), and purchases
related to medical material and equipment (10%), HIV-test
kits (6%) and artiﬁcial milk (60%).
The problem of the progressive loss to follow up is likely
to be associated with the ‘too centralized’ hospital-based
PMTCT implementation strategy. Thyolo is a large rural
district completely without public transport. Asking preg-
nant mothers to return on multiple occasions from remote
areas, either on foot or by bicycle, is unlikely to work.
Understandably, many might have taken the choice of
delivering and following postnatal care at a peripheral site
(health centre or TBA facility) closer to their homes, even if
this meant defaulting from the PMTCT programme. The
reality in most countries in sub-Saharan Africa is that
between 60% and 90% of all deliveries in rural areas occur
outside hospital, mostly at TBA sites (Isenalumbe 1990;
Walraven et al. 1999).
The ﬁnding that the dropout rate in the general antenatal
services (with predominantly HIV-negative mothers) is
similar to that among HIV-positive mothers reassures us
that this is unlikely to be a PMTCT-speciﬁc problem but
rather one that reﬂects the general pattern within the
hospital based antenatal service.
The way forward in addressing the problem of loss to
follow up is likely to lie in improving geographical access
to PMTCT related interventions. Decentralization to per-
ipheral sites (where the great majority of deliveries occur)
and trying to reduce the patient burden related to multiple
hospital visits will have to be the order of the day. From an
operational perspective, there are two possible options,
which are not mutually exclusive.
First, HIV-positive mothers who have been identiﬁed
at Thyolo district hospital could be offered the choice of
being referred to one of the 11 peripheral health centres
or 57 TBA facilities within the district MCH network
where in 2002, 87% of all estimated deliveries in the
district occurred. Introducing nevirapine at these sites
would provide an excellent opportunity for improving
the uptake of nevirapine both for mother and child. The
introduction of the unique ‘health passport’ (patient
retained records) in late 2002, which is now carried by
all antenatal attendees, should facilitate the feasibility of
such referrals. An additional consideration is the possible
impact on cumulative hospital workload.
The second option (desired as a long term goal) would
involve decentralization of counselling, HIV-testing and
nevirapine administration to selected health centres and
TBA sites (Bulterys et al. 2002) already offering routine
antenatal, natal and postnatal services. Peripheral sites
could be chosen on the basis of population coverage and
geographical access. A particular focus on TBA facilities
is however justiﬁed as almost half of all estimated
deliveries in our setting occur at such sites.
In line with decentralization of PMTCT, there are four
important operational considerations. The ﬁrst is the
question of nevirapine administration in babies, which
poses a serious operational challenge (Taha et al. 2003,
2004). The current paediatric formulation of this drug is
a syrup that comes in 25 ml bottles, is light sensitive,
needs to be administered in glass or special plastic
syringes, and has a relatively short shelf life. This makes
it practically impossible to give the mother the baby’s
nevirapine dose (along with her dose) at the 36-week
scheduled antenatal visit. The availability of single-dose
blister packs for newborns would be an important
breakthrough in improving the administration of this
drug to newborns.
The second consideration is whether or not we should
provide breast milk substitutes for artiﬁcial feeding at
peripheral sites. The resources and logistics required to
support such an intervention on a large scale are unlikely to
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setting. In the absence of other options to reduce MTCT
transmission through breast milk, the way forward, at least
for now, would be to limit exclusive breastfeeding (Brah-
mbhatt & Gray 2003) at all PMTCT sites.
The third main consideration is the lack of human
resources at peripheral health facilities, which poses a
serious challenge to decentralization. Currently only 50%
of available posts in the Ministry of Health in Malawi are
ﬁlled (MOHP 1999) and 90% of primary health facilities
are unable to deliver the essential health package
(Zachariah et al. 2004). PMTCT cannot be decentralized
to existing public health facilities without providing the
necessary staff to ﬁll the pre-existing gaps and to cover
the additional workload associated with PMTCT speciﬁc
activities. Conditions of service are also poor, and staff
retention and motivation are important determining
factors that will have to be addressed. In this respect, the
early involvement of TBAs in any decentralization strat-
egy again provides an opportunity to make use of what
has been so far an ‘unexploited’ community resource.
However, in the long run, there would be a need to
increase delivery facilities in health centres in order to
facilitate not just PMTCT related deliveries, but to also
have an impact on maternal mortality rates as a whole.
This unfortunately remains a major challenge in terms of
ﬁnancial and human resources and for the moment is
unaffordable in Malawi.
The fourth consideration concerns the operational
implications that development of resistance to single dose
nevirapine might have. The programme has to be alert to
this and adapt according to emerging knowledge (WHO
2004a,b).
The fact that an estimated 344 HIV-positive mothers
and babies delivered at the Thyolo district hospital
maternity were missed by the PMTCT programme
reﬂects the reality that the only recruitment focus for the
programme was the antenatal service. Even in a cen-
tralized hospital-based PMTCT approach, this potential
‘bottleneck’ should be addressed as soon as it is assessed
that a substantial proportion of women who come to
deliver have received antenatal care elsewhere. Introdu-
cing ‘opt-out’ VCT services in maternity coupled with
intra- and post-partum nevirapine for mother and baby,
or even universal nevirapine upon presentation in labour
would be ways of addressing this missed opportunity
(Stringer et al. 2004).
In Thyolo, the unavoidable price of restricting PMTCT
to a purely Thyolo hospital based (centralized) approach
has been the unacceptably high dropout rate. What is
urgently needed is scaling-up coverage by improving
geographical access through decentralization of the current
programme into MCH networks (including TBA net-
works). In particular, resistance to effective collaboration
between TBAs and medically trained health care workers
will have to be reduced if efforts to prevent perinatal
transmission of HIV are to reach most of the rural
population (Green 1998).
This imperative is made all the more urgent in the light
of recent WHO guidelines that propose the use of
antiretroviral regimens of longer duration (WHO 2004)
that will require closer follow up of mothers and babies.
Following this review, the Thyolo district health services
and MSF decided to urgently reorient the existing pro-
gramme and address bottlenecks. In particular, PMTCT
activities have been successfully decentralized to 6 of the 11
peripheral health centres and steps to actively involve TBA
sites are also underway. In 2001, the United Nations
General Assembly declared its global commitment to
reduce the proportion of HIV-infected infants by 50% by
2010 through PMTCT. It is not enough to simply try to do
more of what we do today. What is urgently needed is the
courage to ‘act differently’ and to ‘learn as one goes’.
Otherwise, in highly HIV prevalent countries such as
Malawi, even the most basic PMTCT interventions will not
be accessible to the majority of HIV-positive mothers and
many thousands of children will continue to get HIV and
will die of AIDS.
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